Mural Oncology appoints Sachiyo Minegishi as independent director and Audit Committee chair

Mural Oncology plc

Appointed as director effective Sept 20, 2024; initial term through 2025 AGM.
Also named Chair of Audit Committee and member of Nominating & Corporate Governance Committee.
Received option for 15,335 ordinary shares at $3.38 (closing price), vesting quarterly over 3 years.
Annual cash compensation of $40,000 plus additional committee fees and equity grants.
Determined independent under Nasdaq rules; no family relationships or transactions with company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sachiyo Minegishi

Director and Chair of the Audit Committee

Mural Oncology plc

Effective: 2024-09-20
Filed: September 23, 2024, 7:59 PM ET

On September 20, 2024, the Board of Directors (the “Board”) of Mural Oncology plc (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, appointed Sachiyo Minegishi as a director in accordance with the Company’s articles of association to serve on the Board with an initial term expiring at the Company’s 2025 annual general meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sachiyo Minegishi was appointed as Director and Chair of the Audit Committee at Mural Oncology plc.

Action: appointed
Role: Director and Chair of the Audit Committee

Exact text from the filing

On September 20, 2024, the Board of Directors (the “Board”) of Mural Oncology plc (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, appointed Sachiyo Minegishi as a director in accordance with the Company’s articles of association to serve on the Board with an initial term expiring at the Company’s 2025 annual general meeting.

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-24-108626

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.